Open access
56
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect
Thomas M Siler1 Midwest Chest Consultants, St Charles, MO, USACorrespondence[email protected]
, Craig F LaForce2 North Carolina Clinical Research, Raleigh, NC, USA
, Farid Kianifard3 Novartis Pharmaceuticals, East Hanover, NJ, USA
, James Williams3 Novartis Pharmaceuticals, East Hanover, NJ, USA
& Selwyn Spangenthal4 Charlotte Lung and Health Center, Charlotte, NC, USA
Pages 919-925
|
Published online: 01 Sep 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.